Literature DB >> 17193121

Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts.

Nadine Pernodet1, Xiaohua Fang, Yuan Sun, Asya Bakhtina, Aditi Ramakrishnan, Jonathan Sokolov, Abraham Ulman, Miriam Rafailovich.   

Abstract

Nanoscale engineering is one of the most dynamically growing areas at the interface between electronics, physics, biology, and medicine. As there are no safety regulations yet, concerns about future health problems are rising. We investigated the effects of citrate/gold nanoparticles at different concentrations and exposure times on human dermal fibroblasts. We found that, as a result of intracellular nanoparticle presence, actin stress fibers disappeared, thereby inducing major adverse effects on cell viability. Thus, properties such as cell spreading and adhesion, cell growth, and protein synthesis to form the extracellular matrix were altered dramatically. These results suggest that the internal cell activities have been damaged.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17193121     DOI: 10.1002/smll.200500492

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  75 in total

Review 1.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

2.  Thermoresponsive Elastin-b-Collagen-Like Peptide Bioconjugate Nanovesicles for Targeted Drug Delivery to Collagen-Containing Matrices.

Authors:  Tianzhi Luo; Michael A David; Lucas C Dunshee; Rebecca A Scott; Morgan A Urello; Christopher Price; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2017-08-01       Impact factor: 6.988

3.  Surface engineering of bismuth nanocrystals to counter dissolution.

Authors:  Shatadru Chakravarty; Jason Unold; Dorela D Shuboni-Mulligan; Barbara Blanco-Fernandez; Erik M Shapiro
Journal:  Nanoscale       Date:  2016-06-29       Impact factor: 7.790

4.  Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.

Authors:  Yi-Hsien Cheng; Jim E Riviere; Nancy A Monteiro-Riviere; Zhoumeng Lin
Journal:  Nanotoxicology       Date:  2018-04-14       Impact factor: 5.913

5.  Citrate gold nanoparticle exposure in the marine bivalve Ruditapes philippinarum: uptake, elimination and oxidative stress response.

Authors:  Moritz Volland; Miriam Hampel; Juan A Martos-Sitcha; Chiara Trombini; Gonzalo Martínez-Rodríguez; Julián Blasco
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-22       Impact factor: 4.223

6.  Global transcriptomic analysis of model human cell lines exposed to surface-modified gold nanoparticles: the effect of surface chemistry.

Authors:  E M Grzincic; J A Yang; J Drnevich; P Falagan-Lotsch; C J Murphy
Journal:  Nanoscale       Date:  2015-01-28       Impact factor: 7.790

7.  Toxicologic effects of gold nanoparticles in vivo by different administration routes.

Authors:  Xiao-Dong Zhang; Hong-Ying Wu; Di Wu; Yue-Ying Wang; Jian-Hui Chang; Zhi-Bin Zhai; Ai-Min Meng; Pei-Xun Liu; Liang-An Zhang; Fei-Yue Fan
Journal:  Int J Nanomedicine       Date:  2010-10-05

8.  Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?

Authors:  Alaaldin M Alkilany; Catherine J Murphy
Journal:  J Nanopart Res       Date:  2010-04-06       Impact factor: 2.253

9.  Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441.

Authors:  Chiara Uboldi; Daniele Bonacchi; Giada Lorenzi; M Iris Hermanns; Christine Pohl; Giovanni Baldi; Ronald E Unger; C James Kirkpatrick
Journal:  Part Fibre Toxicol       Date:  2009-06-22       Impact factor: 9.400

10.  Irradiation stability and cytotoxicity of gold nanoparticles for radiotherapy.

Authors:  Xiao-Dong Zhang; Mei-Li Guo; Hong-Ying Wu; Yuan-Ming Sun; Yan-Qiu Ding; Xin Feng; Liang-An Zhang
Journal:  Int J Nanomedicine       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.